The best Morningstar alternative for stock screening is ScreenerHero for European and global equities, or Finviz for US-only screening. Both cover their respective markets with deeper filter sets, faster interfaces, and lower prices than Morningstar Premium — which is built primarily around analyst ratings, fund research, and portfolio analytics rather than systematic stock screening.
Last updated: June 2026.
Why investors look for Morningstar alternatives
Morningstar built its reputation on mutual fund ratings and analyst research. The star ratings, analyst reports, and portfolio tools are genuinely differentiated products. But three patterns drive investors toward alternatives:
1. You primarily screen stocks, not funds. Morningstar's stock screener exists and is functional, but the platform is designed around fund research. The stock screener is one feature inside a product built for a different primary use case. Dedicated screeners — Finviz, ScreenerHero — offer more filter depth, faster results, and interfaces designed entirely around the screening workflow.
2. Morningstar Premium is expensive relative to what screeners cost. At $199–249/year ($16–21/month), Morningstar Premium is in the price range of dedicated screening tools. But those tools offer deeper filter sets and broader market coverage for the same money, without charging for analyst reports and fund tools you may not use.
3. European stock coverage below large cap is thin. Morningstar covers global stocks broadly but analyst coverage is heavily concentrated on US and major European large caps. For European small-cap and microcap screening — where the most pricing inefficiency exists — Morningstar's data and coverage density drops significantly.
Morningstar vs. alternatives: comparison table
| Feature | Morningstar (free) | Morningstar Premium ($16–21/mo) | ScreenerHero ($29/mo) | Finviz Elite ($39.99/mo) | TIKR Pro ($40–55/mo) |
|---|---|---|---|---|---|
| US large cap | ✓ | ✓ | ✓ | ✓ | ✓ |
| EU large cap | ✓ | ✓ | ✓ | ✗ | ✓ |
| EU small cap / alt markets | Partial | Partial | ✓ | ✗ | Partial |
| Canada | ✓ | ✓ | ✓ | ✗ | ✓ |
| Free no-account tier | ✓ (limited) | — | ✓ | ✓ (US) | ✗ |
| Analyst ratings (stocks) | ✓ (moat, fair value) | ✓ | ✗ | ✗ | ✗ |
| Mutual fund ratings | ✓ | ✓ | ✗ | ✗ | ✗ |
| Raw filter screener | Limited | ✓ | ✓ | ✓ | ✓ |
| Screener-first UX | ✗ | ✗ | ✓ | ✓ | ✗ |
| 10-year financials | ✓ | ✓ | ✗ | ✗ | ✓ |
| Heatmap view | ✗ | ✗ | ✓ | ✓ (US) | ✗ |
| Portfolio X-ray / analytics | ✓ | ✓ | ✗ | ✗ | ✗ |
Data as of June 2026.
The main alternatives to Morningstar in 2026
ScreenerHero — Best for systematic European and global screening
ScreenerHero covers all major European exchanges including alternative markets, plus US and Canadian markets, with 30+ fundamental filters accessible free without an account. For investors who use Morningstar to screen stocks rather than to access analyst ratings or fund tools, ScreenerHero delivers more screener functionality for a comparable price.
What you gain vs. Morningstar: Better European small-cap coverage. Faster, screener-first UX. Heatmap view. Free no-account access to core screener.
What you lose: Morningstar analyst ratings (moat classification, fair value estimates), fund star ratings, portfolio X-ray, and earnings estimate data.
Price: Free (no account) · $29/month Pro
Best for: Equity investors who screen stocks by fundamental criteria and don't rely on Morningstar's analyst ratings or fund data.
Finviz — Best free Morningstar alternative for US stocks
For US equity investors, Finviz's free tier covers 7,000+ US stocks with 60+ filters and requires no account. This matches or exceeds Morningstar's US stock screener depth without any payment.
What you gain vs. Morningstar: More filter depth for US stocks. Faster interface. Technical filters (RSI, moving averages) alongside fundamentals. No payment required.
What you lose: Morningstar analyst coverage, fair value estimates, economic moat ratings, fund tools.
Price: Free (no account, US only) · $39.99/month Elite
Best for: US-focused equity investors who use Morningstar for stock screening rather than fund or analyst research.
Stock Analysis — Best free Morningstar alternative for financial data
Stock Analysis (stockanalysis.com) covers 120,000+ stocks with 10-year historical financial statements at no cost and no account required. For investors who use Morningstar to look up individual company financials, Stock Analysis is a direct free replacement.
What you gain vs. Morningstar: Free. More historical financial data for stocks. Simple, uncluttered interface.
What you lose: Analyst coverage, fair value estimates, fund data, portfolio tools.
Best for: Investors who look up individual stock financials and don't need Morningstar's proprietary analysis.
Simply Wall St — Best Morningstar alternative for narrative-driven investors
If Morningstar's value to you is the narrative analysis — understanding what drives a company's valuation, what the risks are, what analysts expect — Simply Wall St's visual snowflake and plain-language summaries serve a similar need at a lower price ($10–25/month).
What you gain: Lower price. More visual, accessible interface. Broader global coverage for narrative analysis.
What you lose: Morningstar's analyst depth. Fair value methodology. Fund star ratings.
Best for: Investors who want narrative context around individual stocks without paying for full Morningstar access.
TIKR Pro — Best Morningstar alternative for financial statement depth
TIKR Pro's 20-year financial statement history exceeds Morningstar's 10-year depth for stock-specific research, at $40–55/month. For deep fundamental analysis without reliance on analyst ratings, TIKR is a stronger research terminal.
What you gain: Deeper financial history. Earnings transcripts. Screener integration.
What you lose: Morningstar's analyst coverage framework (moat, fair value, uncertainty). Fund tools.
What Morningstar does better than any alternative
Before switching, it's worth being clear about where Morningstar is genuinely differentiated:
Economic moat analysis. Morningstar's moat framework — wide, narrow, or none — is a proprietary, analyst-driven assessment of competitive advantage durability. No screener replicates this because it requires analyst judgment, not just data processing.
Fair value estimates. Morningstar provides analyst-generated fair value estimates for thousands of stocks, giving investors a reference point for intrinsic value without building their own model. This is a genuine product differentiator.
Fund star ratings. If you invest in mutual funds or ETFs and use Morningstar's star ratings and analyst pick designations, there is no credible free alternative. Morningstar's fund analysis is the industry standard.
Portfolio X-ray. Morningstar's portfolio analytics — looking through fund holdings to assess true diversification, sector exposure, and style box positioning — is a unique tool with no direct equivalent in the alternatives listed here.
If any of these are central to your process, Morningstar remains the right tool.
Frequently asked questions
Is there a free Morningstar alternative for stock research?
Stock Analysis provides free 10-year financial data for 120,000+ stocks. ScreenerHero's free tier covers systematic screening across US, Canada, and European exchanges. Finviz covers US stocks free with no account. None replicate Morningstar's proprietary analyst ratings or fair value estimates, but all cover the financial data and screening components for free.
What does Morningstar Premium offer that the free tier doesn't?
Morningstar Premium unlocks full analyst reports with moat classification and price-to-fair-value ratios, the full historical stock screener, portfolio X-ray, and unlimited portfolio tracking. The free tier shows limited data per company and restricts access to analyst reports and fair value estimates.
Is Morningstar good for stock screening?
Morningstar's stock screener is functional but not built for systematic, rapid screening. It lacks the speed and filter depth of dedicated screeners (Finviz for US, ScreenerHero for European and global). Morningstar's comparative advantage is analyst research and fund analysis — the screener is a secondary feature in a product built for different primary use cases.
Which Morningstar alternative has the best European coverage?
ScreenerHero has the most comprehensive European coverage, including alternative markets (Euronext Growth Paris, Nasdaq First North, EGM Milan, GPW NewConnect) that most screeners — including Morningstar — cover poorly below large-cap level.
Can I use ScreenerHero instead of Morningstar?
For systematic stock screening — filtering by P/E, ROE, EV/EBITDA, margins, dividends across global markets — yes. For Morningstar's analyst research (moat ratings, fair value estimates), fund star ratings, and portfolio analytics — no, ScreenerHero does not replicate those features. The right answer depends on which part of Morningstar you actually use.
Related guides
- Best European Stock Screener in 2026 — full comparison of dedicated European screeners
- What Is a Stock Screener? — how screeners work and what metrics they use
- Best Free Stock Screener — top free tools with no sign-up required
- Best Simply Wall St Alternative — visual score tools vs. raw fundamental screeners
- Best TIKR Alternative — for investors who need deep financial statement history
Open the screener → — free, no account required. Filter US, Canada, and European stocks by P/E, ROE, EV/EBITDA, dividends, and more. Pro at $29/month.